Royal Bank Of Canada Statera Biopharma, Inc. Transaction History

Royal Bank Of Canada

  • $422 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$0.08 - $0.15 $16 - $31
208 Added 2311.11%
217 $0
Q3 2022

Nov 14, 2022
BUY
$0.15 - $0.28 $1 - $2
9 New
9 $0
Q1 2022

May 16, 2022
SELL
$0.31 - $2.27 $1,550 - $11,350
-5,000 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$2.01 - $4.08 $10,049 - $20,400
5,000 New
5,000 $12,000

Others Institutions Holding STAB

# of Institutions
4
Shares Held
30K
Call Options Held
0
Put Options Held
0
View Full List

About Statera Biopharma, Inc.

STAB Quotes by TradingView
  • Ticker STAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,295,700
  • Description
  • Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within ...
More about STAB
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email